400|Manuel Serrano Ríos y María Cascales
Bibliografía
1.
Anmadian M, Suh JM, Nah N, Liddle ., Atkins AR, Downes, M y Evans RM (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Nature Medicine
99,
557–566.
Benito M (2006) Resistencia a la Insulina. Diabetes tipo II. En:
Enfermedades Metabólicas (Ed F Mayor y M Cascales) Real Academia Nacional de
Farmacia, Madrid. pp37-‐56.
3.
Benito M (2014) Patologías asociadas a la obesidad. Síndrome metabólico y
diabetes melitus tipo 2. En Primer curso Avanzado sobre Obesidad (eds M
Cascales, F Sánchez Muniz y B Ribas). Monografía XXXVIII de la RANF. Madrid. pp
128 – 148.
4.
Caballero B (2007). The global epidemic of obesity: an overview. Epidemiol Rev
29, 1-‐5.
5.
Calvo-‐Monfil C (2005) Dislipemias y atherosclerosis. En: Bioquímica y
Fisiopatología de la Nutrición (eds M Cascales, D Espinós y P García Barreno).
Instituto de España. Madrid pp 257-‐276
6.
Cascio G, Schiera G, Di Liegro I (2012) Dietary fatty acids in metabolic syndrome,
diabetes and cardiovascular diseases. Curr Diabetes Rev 8, 2-‐17.
7.
De Luca C y Olefsky JM (2009) Inflammation and insulin resistance. FEBS 582, 97-‐
105.
8.
Fernandez-‐Veledo,S, Nieto-‐Vazquez,I, Vila-‐Bedmar,R, Garcia-‐Guerra,L, Alonso-‐
Chamorro,M, Lorenzo,M (2009) Molecular mechanisms involved in obesity-‐
associated insulin resistance: therapeutical approach. Arch Physiol Biochem 115,
227-‐239.
9.
Fuentes E, Guzmán-‐Jofre L, Moore-‐Carrasco R y Palomo I (2013)
Role of PPARs in
inflammatory processes associated with metabolic syndrome (Review) Mol Med
Reports 8, 1611-‐1616.
10.
Fernández-‐Veledo S (2010) Obesidad, inflamación y resistencia a la insulina
SEBBM divulgación.
11.
Hernandez ED, Lee SJ, Kim JY, Duran A, Linares JF, Yajima T, Müller TD, Tschöp MH,
Smith SR, Diaz-‐Meco MT, Moscat J (2014). A macrophage NBR1-‐MEKK3 complex
triggers JNK-‐mediated adipose tissue inflammation in obesity. Cell Metab. 20, 499-‐
511.
12.
Ishibashi J, Seale P. (2010) Medicine. Beige can be slimming. Science. 328, 1113-‐
1114.
13.
Konner AC, Bruning JC.
(2010) Toll-‐like receptors: linking inflammation to
metabolism. Trends Endocrinol Metab. 22:16-‐23.
14.
Lorenzo M y Benito M (2010) From insulin action to hormonal resistance. Old to
recent molecular mechanisms. En: Type 2 Diabetes Mellitus. Eds Serrano-‐Rios, M,
Fuentes Gutierrez JA. Elsevier pp 105-‐130.
15.
Maury,E,
Brichard,SM (2010): Adipokine dysregulation,
adipose tissue
inflammation and metabolic syndrome. Mol Cell Endocrinol 314, 1-‐16.
16.
Nieto-‐Vazquez,I, Fernandez-‐Veledo,S, de Alvaro,C, Lorenzo,M (2008) Dual role of
interleukin-‐6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes
57, 3211-‐3221.
17.
Olefsky JM, Glass CK. (2010) Macrophages, inflammation, and insulin resistance.
Annu Rev Physiol. 72, 219-‐246.
18.
Phillips LK, Prins JB (2008) The link between abdominal obesity and the metabolic
syndrome. Current Hypertension Reports, 10, 156-‐164.
